高尿酸血症相关脑血管病的研究进展

doi:10.3969/j.issn.1673-5765.2021.05.019

摘要/Abstract

摘要：

高尿酸血症与血管内皮功能障碍、动脉粥样硬化及心脑血管事件发生密切相关。高尿酸血症与卒中发生及预后相关研究的结论存在争议，更多的研究倾向高尿酸血症增加了卒中发生风险，而在卒中患者预后方面，近期研究表明尿酸水平升高可改善其预后，主要得益于尿酸的抗氧化及神经保护作用等。同时，高尿酸血症可增加脑小血管病的发生风险，从而引起认知功能下降。

文章导读： 高尿酸血症与卒中发生及预后相关研究的结论存在争议，更多的研究倾向高尿酸血症增加了卒中发生风险，而在卒中患者预后方面，近期研究表明尿酸水平的升高可改善其预后，主要得益于尿酸的抗氧化及神经保护作用等。

关键词: 高尿酸血症; 尿酸; 卒中; 脑小血管病; 发病机制

Abstract:

Hyperuricemia is closely related to vascular endothelial dysfunction, atherosclerosis and cardiovascular and cerebrovascular events. The relationship of hyperuricemia with the occurrence and prognosis of stroke is controversial, more studies suggested that hyperuricemia increased the risk of stroke. While recent studies showed that uric acid concentration increase can improve the prognosis, which maybe be related to the antioxidant and neuroprotective effect of uric acid. Meanwhile, hyperuricemia can increase the risk of cerebral small vessel disease, resulting in the decline of cognitive function.

Key words: Hyperuricemia; Uric acid; Stroke; Cerebral small vessel disease; Pathogenesis

陆皓璇，马笑笑，娄昕. 高尿酸血症相关脑血管病的研究进展[J]. 中国卒中杂志, 2021, 16(05): 524-528.

LU Hao-Xuan, MA Xiao-Xiao, LOU Xin. Progress of Hyperuricemia Related Cerebrovascular Diseases[J]. Chinese Journal of Stroke, 2021, 16(05): 524-528.

参考文献

[1] DALBETH N，CHOI H K，JOOSTEN L A B，et al.

Gout[J]. Nat Rev Dis Primers，2019，5（1）：69.

[2] CHEN X M，YOKOSE C，RAI S K，et al.

Contemporary prevalence of gout and hyperuricemia

in the United States and decadal trends：the National

Health and Nutrition Examination Survey，2007-

2016[J]. Arthritis Rheumatol，2019，71（6）：991-999.

[3] TU W，WU J，JIAN G，et al. Asymptomatic

hyperuricemia and incident stroke in elderly Chinese

patients without comorbidities[J]. Eur J Clin Nutr，

2019，73（10）：1392-1402.

[4] ZHONG C K，ZHONG X Y，XU T，et al. Sexspecific

relationship between serum uric acid and

risk of stroke：a dose-response meta-analysis of

prospective studies[J/OL]. J Am Heart Assoc，2017，

6（4）：e005042[2020-01-01]. https：//doi.org/10.1161/

JAHA.116.005042.

[5] LI M，HOU W S，ZHANG X W，et al.

Hyperuricemia and risk of stroke：a systematic

review and meta-analysis of prospective studies[J].

Atherosclerosis，2014，232（2）：265-270.

[6] BOS M J，KOUDSTAAL P J，HOFMAN A，et al.

Uric acid is a risk factor for myocardial infarction

and stroke：the Rotterdam study[J]. Stroke，2006，37

（6）：1503-1507.

[7] ZHANG W，ISO H，MURAKAMI Y，et al. Serum

uric acid and mortality form cardiovascular disease：

EPOCH-JAPAN study[J]. J Atheroscler Thromb，

2016，23（6）：692-703.

[8] JIMÉNEZ M C，CURHAN G C，CHOI H K，et

al. Plasma uric acid concentrations and risk of

ischaemic stroke in women[J]. Eur J Neurol，2016，23

（7）：1158-1164.

[9] KIM S Y，GUEVARA J P，KIM K M，et al.

Hyperuricemia and risk of stroke：a systematic

review and meta-analysis[J]. Arthritis Rheum，2009，

61（7）：885-892.

[10] HOLME I，AASTVEIT A H，HAMMAR N，et al.

Uric acid and risk of myocardial infarction，stroke

and congestive heart failure in 417，734 men and

women in the Apolipoprotein MOrtality RISk study

（AMORIS）[J]. J Intern Med，2009，266（6）：558-

570.

[11] WEIR C J，MUIR S W，WALTERS M R，et al.

Serum urate as an independent predictor of poor

outcome and future vascular events after acute

stroke[J]. Stroke，2003，34（8）：1951-1956.

[12] 汪云云，谢小华，任力杰，等. 血尿酸水平与急性缺血

性卒中病情严重程度和预后的关系研究[J]. 中国卒

中杂志，2019，14（3）：207-212.

[13] WANG Z C，LIN Y L，LIU Y X，et al. Serum

uric acid levels and outcomes after acute ischemic

stroke[J]. Mol Neurobiol，2016，53（3）：1753-1759.

[14] JIN M，YANG F，YANG I，et al. Uric acid，

hyperuricemia and vascular diseases[J/OL]. Front

Biosci（Landmark Ed），2012，17：656-669[2020-01-

01]. https：//doi.org/10.2741/3950.

[15] CHAUDHARY N S，BRIDGES S L Jr，SAAG

K G，et al. Severity of hypertension mediates the

association of hyperuricemia with stroke in the

REGARDS case cohort study[J]. Hypertension，2019，

75（1）：246-256.

[16] YA B L，LIU Q，LI H F，et al. Uric acid protects

against focal cerebral ischemia/reperfusion-induced

oxidative stress via activating Nrf2 and regulating

neurotrophic factor expression[J/OL]. Oxid Med Cell

Longev，2018，2018：6069150[2020-01-01].https：//doi.org/10.1155/2018/6069150.

[17] VILA E，SOLÉ M，MASIP N，et al. Uric acid

treatment after stroke modulates the Krüppel-like

factor 2-VEGF-A axis to protect brain endothelial

cell functions：impact of hypertension[J/OL].

Biochem Pharmacol，2019，164：115-128[2020-01-

01]. https：//doi.org/10.1016/j.bcp.2019.04.002.

[18] CROSTA F，OCCHIUZZI U，PASSALACQUA G，

et al. Association between the serum uric acid levels

and lacunar infarcts in the elderly[J]. J Mol Neurosci，

2018，65（3）：385-390.

[19] SHIH C Y，CHEN C Y，WEN C J，et al. Relationship

between serum uric acid and cerebral white matter

lesions in the elderly[J]. Nutr Metab Cardiovasc Dis，

2012，22（2）：154-159.

[20] SCHRETLEN D J，INSCORE A B，

VANNORSDALL T D，et al. Serum uric acid and

brain ischemia in normal elderly adults[J]. Neurology，

2007，69（14）：1418-1423.

[21] VANNORSDALL T D，JINNAH H A，GORDON B，

et al. Cerebral ischemia mediates the effect of serum

uric acid on cognitive function[J]. Stroke，2008，39

（12）：3418-3420.

[22] YANG S N，ZHANG X Y，YUAN J L，et al. Serum

uric acid is independently associated with enlarged

perivascular spaces[J]. Sci Rep，2017，7（1）：16435.

[23] JEONG S M，YOO T G，NAM Y S，et al. Sexdependent

effects of uric acid on cerebral microbleed：

a cross-sectional study in the general population[J].

Eur J Neurol，2017，24（10）：1300-1306.

[24] VERHAAREN B F，VERNOOIJ M W，DEHGHAN

A，et al. The relation of uric acid to brain atrophy

and cognition：the Rotterdam scan study[J].

Neuroepidemiology，2013，41（1）：29-34.

[25] ZHAGN X Y，DING L L，YANG L，et al.

Brain atrophy correlates with severe enlarged

perivascular spaces in basal ganglia among lacunar

stroke patients[J/OL]. PLoS One，2016，11（2）：

e0149593[2020-01-01]. https：//doi.org/10.1371/

journal.pone.0149593.

[26] RYU W S，KIM C K，KIM B J，et al. Serum uric

acid levels and cerebral microbleeds in patients with

acute ischemic stroke[J/OL]. PLoS One，2013，8（1）：

e55210[2020-01-01]. https：//doi.org/10.1371/journal.

pone.0055210.

[27] SINGH J A，YU S. Allopurinol and the risk of stroke

in older adults receiving medicare[J]. BMC Neurol，

2016，16（1）：164.

[28] AKKINENI R，TAPP S，TOSTESON A N A，et

al. Treatment of asymptomatic hyperuricemia and

prevention of vascular disease：a decision analytic

approach[J]. J Rheumatol，2014，41（4）：739-748.

[29] TANAKA A，TAGUCHI I，TERAGAWA H，et al.

Febuxostat does not delay progression of carotid

atherosclerosis in patients with asymptomatic

hyperuricemia：a randomized，controlled trial[J/OL].

PLoS Med，2020，17（4）：e1003095[2020-01-01].

https：//doi.org/10.1371/journal.pmed.1003095.

[30] AMARO S，LAREDO C，RENÚ A，et al. Uric acid

therapy prevents early ischemic stroke progression：a

tertiary analysis of the URICO-ICTUS trial（efficacy

study of combined treatment with uric acid and r-tPA

in acute ischemic stroke）[J]. Stroke，2016，47（11）：

2874-2876.

[31] AMARO S，LLULL L，RENÚ A，et al. Uric acid

improves glucose-driven oxidative stress in human

ischemic stroke[J]. Annals of neurology，2015，77

（5）：775-783.

[32] LLULL L，LAREDO C，RENÚ A，et al. Uric acid

therapy improves clinical outcome in women with

acute ischemic stroke[J]. Stroke，2015，46（8）：

2162-2167.

[33] CHAMORRO Á，AMARO S，CASTELLANOS

M，et al. Uric acid therapy improves the outcomes

of stroke patients treated with intravenous

tissue plasminogen activator and mechanical

thrombectomy[J]. Int J Stroke，2017，12（4）：377-

382.

[34] CHAMORRO A，AMARO S，CASTELLANOS

M，et al. Safety and efficacy of uric acid in patients

with acute stroke（URICO-ICTUS）：a randomised，

double-blind phase 2b/3 trial[J]. Lancet Neurol，2014，

13（5）：453-460.